The estimated Net Worth of Manoj Maniar is at least $662 Tausend dollars as of 30 June 2016. Manoj Maniar owns over 50 units of Onconova Therapeutics Inc stock worth over $50 and over the last 9 years he sold ONTX stock worth over $0. In addition, he makes $662,385 as Senior Vice President - Product Development at Onconova Therapeutics Inc.
Sign up
Manoj Maniar ONTX stock SEC Form 4 insiders trading
Manoj has made over 1 trades of the Onconova Therapeutics Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 50 units of ONTX stock worth $325 on 30 June 2016.
The largest trade he's ever made was exercising 50 units of Onconova Therapeutics Inc stock on 30 June 2016 worth over $325. On average, Manoj trades about 5 units every 0 days since 2015. As of 30 June 2016 he still owns at least 50 units of Onconova Therapeutics Inc stock.
You can see the complete history of Manoj Maniar stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Manoj Maniar biography
Dr. Manoj Maniar, Ph.D., serves as Senior Vice President - Product Development of Onconova Therapeutics, Inc. Prior to joining the Company, Dr. Maniar was with SRI International, Inc., a nonprofit research institute, where he served as Senior Director, Formulations and Drug Delivery. Dr. Maniar received his B.S. in Pharmacy from Bombay College of Pharmacy and his Ph.D. in Pharmaceutics from the University of Connecticut.
What is the salary of Manoj Maniar?
As the Senior Vice President - Product Development of Onconova Therapeutics Inc, the total compensation of Manoj Maniar at Onconova Therapeutics Inc is $662,385. There are 1 executives at Onconova Therapeutics Inc getting paid more, with Dr. Steven M. Fruchtman having the highest compensation of $865,438.
How old is Manoj Maniar?
Manoj Maniar is 52, he's been the Senior Vice President - Product Development of Onconova Therapeutics Inc since 2005. There are 9 older and 2 younger executives at Onconova Therapeutics Inc. The oldest executive at Onconova Therapeutics Inc is Henry Bienen, 77, who is the Director.
What's Manoj Maniar's mailing address?
Manoj's mailing address filed with the SEC is C/O ONCONOVA THERAPEUTICS, INC., 375 PHEASANT RUN, NEWTOWN, PA, 18940.
Insiders trading at Onconova Therapeutics Inc
Over the last 12 years, insiders at Onconova Therapeutics Inc have traded over $1,631,795 worth of Onconova Therapeutics Inc stock and bought 27,892,613 units worth $51,994,589 . The most active insiders traders include Capital, Llc Armistice Capi..., Capital Management, Llc 683 und Capital Partners L P Tyndall. On average, Onconova Therapeutics Inc executives and independent directors trade stock every 40 days with the average trade being worth of $294,478. The most recent stock trade was executed by Mark Patrick Guerin on 13 March 2024, trading 8,666 units of ONTX stock currently worth $8,666.
What does Onconova Therapeutics Inc do?
onconova therapeutics, inc. (nasdaq: ontx) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. using a proprietary chemistry platform, onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. onconova has three product candidates in clinical trials and six active pre-clinical programs. onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.
What does Onconova Therapeutics Inc's logo look like?
Complete history of Manoj Maniar stock trades at Onconova Therapeutics Inc
Onconova Therapeutics Inc executives and stock owners
Onconova Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Dr. Steven M. Fruchtman,
CEO, Pres & Director -
Manoj Maniar,
Senior Vice President - Product Development -
Mark Patrick Guerin CPA,
Chief Financial Officer -
Terri Shoemaker,
Director -
James Marino,
Chairman of the Board -
Anne VanLent,
Director -
Jack Stover,
Director -
Viren Mehta,
Director -
Jerome Groopman,
Director -
Henry Bienen,
Director -
Abraham Oler,
Vice President, Corporate Development and General Counsel -
Mark Guerin,
Chief Financial Officer -
Steven Fruchtman,
President, Chief Executive Officer, Director -
Dr. Ramesh Kumar Ph.D.,
Advisor -
Dr. Mark Stephen Gelder,
Chief Medical Officer -
Abraham N. Oler J.D., M.B.A., Esq., CFA,
Sr. VP of Corp. Devel. & Gen. Counsel -
Capital Management, Llc683 ...,
-
Capital Management, Llc683 ...,
-
Ramesh Kumar,
President and CEO -
Michael B Hoffman,
Director -
E Premkumar Reddy,
Director -
Capital Partners L P Tyndall,
10% owner -
Richard Charles Woodman,
Chief Medical Officer -
Capital Management, Llc 683,
10% owner -
Healthcare Sa Baxter,
10% owner -
Ajay Bansal,
Chief Financial Officer -
Thomas J Mckearn,
President, R&D -
& Jane Hoffman 2013 Descend...,
10% owner -
James Altland,
SVP, Finance & Corp. Develop. -
Healthcare Sabaxter Interna...,
-
Capital, Llc Armistice Capi...,
-
Mary Teresa Shoemaker,
-
Victor M Moyo,
CHIEF MEDICAL OFFICER -
Mark S. Md Gelder,
CHIEF MEDICAL OFFICER -
Peter Atadja,
-
Trafford Clarke,